Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma

Medicine and Dentistry

• Multiple Myeloma 100%
• Indoleamine 2,3 Dioxygenase 70%
• Scatter Factor 50%
• Patient 50%
• Myeloma Cell 40%
• Cells 30%
• Differentiation 30%
• Tryptophan 20%
• Kynurenine 20%
• Immune System 20%
• Cytotoxic T-Cell 20%
• Diseases 10%
• Immunosuppressive Treatment 10%
• Malignant Neoplasm 10%
• Protein 10%
• In Vitro 10%
• Secretion (Process) 10%
• Microenvironment 10%
• Plasma Cell 10%
• Immune Disorder 10%
• Phosphorylation 10%
• Myeloma 10%
• Monoclonal Gammopathy of Unknown Significance 10%
• N (3 Chlorophenyl) 3 [3,5 Dimethyl 4 (4 Methyl 1 Piperazinylcarbonyl) 1h Pyrrol 2 Ylmethylene] 2,3 Dihydro N Methyl 2 Oxo 1h Indole 5 Sulfonamide 10%
• N Methyltryptophan 10%
• Smouldering Myeloma 10%
• Scatter Factor Receptor 10%
• Inpatient 10%
• Cancer 10%
• T Cell 10%
• T-Helper Cell 10%
• Regulatory T Cell 10%